The eye is such a complex mechanism that it can’t be dealt with effectively in blog posts. The more we know about it, the more we know that we don’t know. And, of all our five senses, vision is the one we know the most about. Here at ProgenCell, we have successfully treated many cases of macular degeneration and retinitis pigmentosa,
Doctor Luis Romero made a video in Spanish about a friend who suffers from Parkinson’s disease. It deserves a wider audience, so we have translated his presentation into English here.
Here is a case of a patient with Parkinson’s who has been with us for a little over a year. Aside from being a good friend,
The short answer is that we still don’t know.
In saying that, ProgenCell takes a very conservative approach to the meaning of “cure”. We generally use the terms “treatment” and “therapy” to describe our work. When stem cell therapy is successful, all it really does is to help the patient’s body heal itself.
As scientists,
Parkinson’s disease is a degenerative disorder of the central nervous system that often impairs speech and other motor functions. Its symptoms include muscle rigidity, tremors, and the slowing of physical movement to a total loss of physical movement in the worst cases. Secondary symptoms may include autonomic, cognitive, and linguistic impairment. Parkinson’s disease is chronic,
In adults, stem cells are created in the bone marrow and then distributed to the rest of the body through the blood system. It stands to reason that stem cells might be harvested from either location, but there is an important difference both in quantity and in quality between the stem cells found at the source and those found on the periphery of the body.
Barely twelve months ago, the University of California San Diego opened their $127,000,000 stem cell research center to a blitz of media hoopla. And yet, just a few miles down the road, ProgenCell had already spent more than a decade quietly bringing stem cells to patients who need them. What might explain such a contrast?